NLS Pharmaceutics AG Alpha and Beta Analysis

NLSPDelisted Stock  USD 7.62  0.08  1.04%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as NLS Pharmaceutics AG. It also helps investors analyze the systematic and unsystematic risks associated with investing in NLS Pharmaceutics over a specified time horizon. Remember, high NLS Pharmaceutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to NLS Pharmaceutics' market risk premium analysis include:
Beta
(0.76)
Alpha
(1.13)
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although NLS Pharmaceutics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, NLS Pharmaceutics did 1.13  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of NLS Pharmaceutics AG stock's relative risk over its benchmark. NLS Pharmaceutics has a beta of 0.76  . As returns on the market increase, returns on owning NLS Pharmaceutics are expected to decrease at a much lower rate. During the bear market, NLS Pharmaceutics is likely to outperform the market. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

NLS Pharmaceutics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. NLS Pharmaceutics market risk premium is the additional return an investor will receive from holding NLS Pharmaceutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NLS Pharmaceutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate NLS Pharmaceutics' performance over market.
α-1.13   β-0.76

NLS Pharmaceutics Fundamentals Vs Peers

Comparing NLS Pharmaceutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze NLS Pharmaceutics' direct or indirect competition across all of the common fundamentals between NLS Pharmaceutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as NLS Pharmaceutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of NLS Pharmaceutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing NLS Pharmaceutics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare NLS Pharmaceutics to competition
FundamentalsNLS PharmaceuticsPeer Average
Return On Equity-8.63-0.31
Return On Asset-0.76-0.14
Current Valuation10.18 M16.62 B
Shares Outstanding5.21 M571.82 M
Shares Owned By Insiders19.48 %10.09 %
Shares Owned By Institutions5.89 %39.21 %
Number Of Shares Shorted95.16 K4.71 M

NLS Pharmaceutics Opportunities

NLS Pharmaceutics Return and Market Media

The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Best data tools to analyze NLS Pharmaceutics AG stock - CEO Change Weekly Return Optimization Alerts - Newser
08/25/2025
2
Hedge Fund Bets Why is NLS Pharmaceutics AG stock going down - Product Launch Safe Entry Momentum Tips -
09/16/2025
3
NLS Pharmaceutics AG Stock Analysis and Forecast - Cup and Handle Formations High Profit Market Ideas - Early Times
09/26/2025
4
Is NLS Pharmaceutics AG stock positioned well for digital economy - Weekly Trend Recap Technical Pattern Based Signals - newser.com
10/02/2025
5
Why NLS Pharmaceutics AG Equity Warrant stock is recommended by analysts - Quarterly Portfolio Summary AI Based Buy and Sell Signals - newser.com
10/16/2025
6
NLS Pharmaceutics AG stock trend outlook and recovery path - Quarterly Profit Report High Conviction Buy Zone Alerts - newser.com
10/20/2025
7
NLS Pharmaceutics AG stock trend outlook and recovery path - July 2025 News Drivers Risk Adjusted Swing Trade Ideas - newser.com
10/24/2025
8
NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies
10/27/2025
9
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
10/30/2025

About NLS Pharmaceutics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NLS or other delisted stocks. Alpha measures the amount that position in NLS Pharmaceutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

NLS Pharmaceutics Upcoming Company Events

As portrayed in its financial statements, the presentation of NLS Pharmaceutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NLS Pharmaceutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of NLS Pharmaceutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of NLS Pharmaceutics. Please utilize our Beneish M Score to check the likelihood of NLS Pharmaceutics' management manipulating its earnings.
3rd of May 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with NLS Pharmaceutics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in NLS Stock

If you are still planning to invest in NLS Pharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NLS Pharmaceutics' history and understand the potential risks before investing.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bonds Directory
Find actively traded corporate debentures issued by US companies
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
FinTech Suite
Use AI to screen and filter profitable investment opportunities